✦ LIBER ✦

Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis

✍ Scribed by J. R. Graybill; R. Bocanegra; M. Luther

Publisher: Springer
Year: 1995
Tongue: English
Weight: 348 KB
Volume: 14
Category: Article
ISSN: 0934-9723
DOI: 10.1007/bf01690878

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination Therapy With Recombinant Hum

Combination Therapy With Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin in Aplastic Anemia

✍ Dr. Masahiro Imamura; Masanobu Kobayashi; Sumiko Kobayashi; Kohki Yoshida; Chika 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients

Failure of combination therapy with reco

Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodyspplastic syndromes

✍ M. Imamura; S. Kobayashi; K. Sakurada; T. Miyazaki; M. Kobayashi; K. Yoshida; C. 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 329 KB

Interstitial pneumonia induced by combin

Interstitial pneumonia induced by combination therapy with low-dose cytarabine and granulocyte colony-stimulating factor

✍ Shigeki Motomura; Shin Fujisawa; Katsumichi Fujimaki; Hiroshi Mohri; Takao Okubo 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Combination therapy with sorafenib and S

Combination therapy with sorafenib and S-1 for renal cell carcinoma producing granulocyte colony-stimulating factor

✍ Yoko Kyono; Tatsuya Takayama; Mana Kinoshita; Yutaka Kurita; Soichi Mugiya; Sato 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 515 KB

Combination chemotherapy with granulocyt

Combination chemotherapy with granulocyte-macrophage–colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma

✍ Susan Partyka; Pamela Dumas; Jaffer Ajani 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

## BACKGROUND. A combination of etoposide, 5-fluorouracil, and folinic acid (ELF) remains popular for the treatment of patients with gastric carcinoma and has been reported to result in a response rate of up to 40% with good patient tolerance. The authors elected to add granulocyte-macrophage-colo

Treatment of de novo acute myelogenous l

Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: Effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts

✍ Valent, Peter ;Sillaber, Christian ;Geissler, Klaus ;Andreeff, Michael ;Tafuri, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of